# A Critical Inflection Point: The Indisputable Case for Next-Gen Pharmacovigilance - Articles, Resources - September 12, 2025 Qinecsa COO, John Cogan, has been featured in Pharmaceutical Outsourcing’s latest issue, where he discusses why adverse event case processing is an enormous cost center and compliance issue for life sciences and outsourcing can alleviate pressure, free up internal resources, and drive down cost. [Read article](https://www.pharmoutsourcing.com/Featured-Articles/621021-A-Critical-Inflexion-Point-The-Indisputable-Case-for-Next-Gen-Pharmacovigilance/) ## Recent Articles ### [The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?](/content/resources/the-productivity-crisis-that-persists-even-now-what-will-it-take-to-free-up-pv-professionals-to-assess-safety-rather-than-coordinate-data/index.html) - July 28, 2026 ### [Embracing quantitative signal detection methods as a smaller MAH](/content/resources/embracing-quantitative-signal-detection-methods-as-a-smaller-mah/index.html) - June 25, 2026 ### [Real-Time Safety Signals Drive Continuous PV Insight](/content/articles/real-time-safety-signals-drive-continuous-pv-insight/index.html) - May 27, 2026 ### [From Complaint Handling to Active Surveillance](/content/resources/from-complaint-handling-to-active-surveillance/index.html) - May 5, 2026 ### [Continuous Safety Surveillance for Medical Devices](/content/resources/continuous-safety-surveillance-for-medical-devices/index.html) - May 5, 2026 ### [Are patient outcomes getting lost in safety data complexity?](/content/resources/are-patient-outcomes-getting-lost-in-safety-data-complexity/index.html) - May 5, 2026 [PreviousAI Encompassing: From Soaring Caseloads to Broadened Biopharma Territory](/content/resources/ai-encompassing-from-soaring-caseloads-to-broadened-biopharma-territory/index.html) [NextStaying Ahead of Regulatory Revisions](/content/resources/staying-ahead-of-regulatory-revisions/index.html)